Works matching IS 02683369 AND DT 2011 AND VI 46 AND IP 1

Results: 33

Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 119, doi. 10.1038/bmt.2010.52

By:

Verdeguer, A.;
de Heredia, C. D.;
González, M.;
Martínez, A. M.;
Fernández-Navarro, J. M.;
Pérez-Hurtado, J. M.;
Badell, I.;
Gómez, P.;
González, M. E.;
Muñoz, A.;
Díaz, M. A.

Publication type:

Article

Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 70, doi. 10.1038/bmt.2010.83

By:

Cohen, Y. C.;
Scaradavou, A.;
Stevens, C. E.;
Rubinstein, P.;
Gluckman, E.;
Rocha, V.;
Horowitz, M. M.;
Eapen, M.;
Nagler, A.;
Shpall, E. J.;
Laughlin, M. J.;
Daniely, Y.;
Pacheco, D.;
Barishev, R.;
Olmer, L.;
Freedman, L. S.

Publication type:

Article

Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 98, doi. 10.1038/bmt.2010.65

By:

Dietz, A. C.;
Orchard, P. J.;
Baker, K. S.;
Giller, R. H.;
Savage, S. A.;
Alter, B. P.;
Tolar, J.

Publication type:

Article

Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 84, doi. 10.1038/bmt.2010.55

By:

Mickelson, D. M.;
Sproat, L.;
Dean, R.;
Sobecks, R.;
Rybicki, L.;
Kalaycio, M.;
Pohlman, B.;
Sweetenham, J.;
Andresen, S.;
Bolwell, B.;
Copelan, E .A.

Publication type:

Article

Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 105, doi. 10.1038/bmt.2010.71

By:

Yoon, D. H.;
Lee, D. H.;
Choi, D. R.;
Sohn, B. S.;
Kim, S.;
Kim, S. W.;
Lee, J. S.;
Lee, S. W.;
Huh, J.;
Suh, C.

Publication type:

Article

Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 137, doi. 10.1038/bmt.2010.67

By:

Lavergne, V.;
Ghannoum, M.;
Weiss, K.;
Roy, J.;
Béliveau, C.

Publication type:

Article

H1N1 infection mimicking the clinical presentation of gastrointestinal GVHD in a patient following allo-SCT.

Published in:

2011

By:

Frangoul, H.;
Domm, J.;
Denison, M. R.;
Calder, C.;
Black, J.

Publication type:

Letter

Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 77, doi. 10.1038/bmt.2010.122

By:

Kawa, K.;
A.Sawada;
Sato, M.;
Okamura, T.;
Sakata, N.;
Kondo, O.;
Kimoto, T.;
Yamada, K.;
Tokimasa, S.;
Yasui, M.;
Inoue, M.

Publication type:

Article

Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 90, doi. 10.1038/bmt.2010.64

By:

Yanagisawa, R.;
Katsuyama, Y.;
Shigemura, T.;
Saito, S.;
Tanaka, M.;
Nakazawa, Y.;
Sakashita, K.;
Shiohara, M.;
Koike, K.

Publication type:

Article

Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 116, doi. 10.1038/bmt.2010.92

By:

Choi, I.;
Tanosaki, R.;
Uike, N.;
Utsunomiya, A.;
Tomonaga, M.;
Harada, M.;
Yamanaka, T.;
Kannagi, M.;
Okamura, J.

Publication type:

Article

Auto-SCT induces a phenotypic shift from CMP to GMP progenitors, reduces clonogenic potential and enhances in vitro and in vivo cycling activity defined by <sup>18</sup>F-FLT PET scanning.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 110, doi. 10.1038/bmt.2010.75

By:

Woolthuis, C.;
Agool, A.;
Olthof, S.;
Slart, R. H J A;
Huls, G.;
Smid, W. M.;
Schuringa, J. J.;
Vellenga, E.

Publication type:

Article

Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 143, doi. 10.1038/bmt.2010.68

By:

Schub, N.;
Günther, A.;
Schrauder, A.;
Claviez, A.;
Ehlert, C.;
Gramatzki, M.;
Repp, R.

Publication type:

Article

Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 59, doi. 10.1038/bmt.2010.63

By:

Nazha, A.;
Cook, R.;
Vogl, D. T.;
Mangan, P. A.;
Gardler, M.;
Hummel, K.;
Cunningham, K.;
Luger, S. M.;
Porter, D. L.;
Schuster, S.;
O'Doherty, U.;
Siegel, D.;
Stadtmauer, E. A.

Publication type:

Article

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 34, doi. 10.1038/bmt.2010.81

By:

Uberti, J. P.;
Agovi, M.-A.;
Tarima, S.;
Haagenson, M.;
Gandham, S.;
Anasetti, C.;
Baker, K. S.;
Bolwell, B. J.;
Bornhauser, M.;
Chan, K. W.;
Copelan, E.;
Davies, S. M.;
Finke, J.;
Hale, G. A.;
Kollman, C.;
McCarthy, P. L.;
Ratanatharathorn, V.;
Ringdén, O.;
Weisdorf, D. J.;
Rizzo, J. D.

Publication type:

Article

Unrelated hematopoietic stem cell donors as research subjects.

Published in:

2011

By:

Appelbaum, F. R.

Publication type:

Opinion

Regulation of donor participation in research studies: is there another way?

Published in:

2011

By:

Apperley, J. F.

Publication type:

Opinion

Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD.

Published in:

2011

By:

Faraci, M.;
Lanino, E.;
Morreale, G.;
Giardino, S.;
Fossati, M.;
Moroni, C.;
Caviglia, I.;
Castagnola, E.

Publication type:

Letter

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 125, doi. 10.1038/bmt.2010.70

By:

Viganò, M.;
Vener, C.;
Lampertico, P.;
Annaloro, C.;
Pichoud, C.;
Zoulim, F.;
Facchetti, F.;
Poli, F.;
Scalamogna, M.;
Deliliers, G. Lambertenghi;
Colombo, M.

Publication type:

Article

Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.

Published in:

2011

By:

Tachibana, T.;
Takasaki, H.;
Tanaka, M.;
Maruta, A.;
Hyo, R.;
Ishigatsubo, Y.;
Kanamori, H.

Publication type:

Letter

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 20, doi. 10.1038/bmt.2010.53

By:

Long-Boyle, J. R.;
Green, K. G.;
Brunstein, C. G.;
Cao, Q.;
Rogosheske, J.;
Weisdorf, D. J.;
Miller, J. S.;
Wagner, J. E.;
McGlave, P. B.;
Jacobson, P. A.

Publication type:

Article

Unrelated hematopoietic stem cell donors as research subjects.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 10, doi. 10.1038/bmt.2010.37

By:

King, R. J.;
Confer, D. L.;
Greinix, H. T.;
Halter, J.;
Horowitz, M.;
Schmidt, A. H.;
Costeas, P.;
Shaw, B.;
Egeland, T.

Publication type:

Article

Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 1, doi. 10.1038/bmt.2010.198

By:

McClune, B. L.;
Polgreen, L. E.;
Burmeister, L. A.;
Blaes, A. H.;
Mulrooney, D. A.;
Burns, L. J.;
Majhail, N. S.

Publication type:

Article

Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 18, doi. 10.1038/bmt.2010.258

By:

Gottschalk, S.

Publication type:

Article

Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 27, doi. 10.1038/bmt.2010.60

By:

McPherson, M. E.;
Hutcherson, D.;
Olson, E.;
Haight, A. E.;
Horan, J.;
Chiang, K.-Y.

Publication type:

Article

Enshrining donor rights and optimizing patient outcome in unrelated donor transplantation.

Published in:

2011

By:

Craddock, C.

Publication type:

Opinion

Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis.

Published in:

2011

By:

Okamura, A.;
Shimoyama, M.;
Ishii, S.;
Wakahashi, K.;
Asada, N.;
Kawano, H.;
Kawamori, Y.;
Nishikawa, S.;
Minagawa, K.;
Katayama, Y.;
Matsui, T.

Publication type:

Letter

Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 64, doi. 10.1038/bmt.2010.78

By:

Costa, L. J.;
Alexander, E. T.;
Hogan, K. R.;
Schaub, C.;
Fouts, T. V.;
Stuart, R. K.

Publication type:

Article

Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 132, doi. 10.1038/bmt.2010.76

By:

Morello, E.;
Pagani, L.;
Coser, P.;
Cavattoni, I.;
Cortelazzo, S.;
Casini, M.;
Billio, A.;
Rossi, G.

Publication type:

Article

Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma.

Published in:

2011

By:

Yhim, H. Y.;
Kwon, D. H.;
Lee, N. R.;
Song, E. K.;
Yim, C. Y.;
Kwak, J. Y.

Publication type:

Letter

Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 44, doi. 10.1038/bmt.2010.84

By:

Johnsen, H. E.;
Geisler, C.;
Juvonen, E.;
Remes, K.;
Juliusson, G.;
H&x#x00F6;rnsten, P.;
Kvaloy, S.;
Kvalheim, G.;
Jürgensen, G. W.;
Pedersen, L. M.;
Bergmann, O. J.;
Schmitz, A.;
Boegsted, M.

Publication type:

Article

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 52, doi. 10.1038/bmt.2010.54

By:

Duarte, R. F.;
Shaw, B. E.;
Marín, P.;
Kottaridis, P.;
Ortiz, M.;
Morante, C.;
Delgado, J.;
Gayoso, J.;
Goterriz, R.;
Martínez-Chamorro, C.;
Mateos-Mazón, J. J.;
Ramírez, C.;
de la Rubia, J.;
Achtereekte, H.;
Gandhi, P. J.;
Douglas, K. W.;
Russell, N. H.

Publication type:

Article

Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation.

Published in:

2011

By:

Girnius, S.;
Seldin, D. C.;
Quillen, K.;
Dember, L. M.;
Segal, A.;
Sanchorawala, V.

Publication type:

Letter

Black hole in the lung.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 1, p. 154, doi. 10.1038/bmt.2010.72

By:

Cantoni, N.;
Weisser, M.;
Frei, R.;
Lardinois, D.;
Arber, C.

Publication type:

Article